Chinese Medicine Combined With EGFR-TKIs Prolongs Progression-Free Survival and Overall Survival of Non-small Cell Lung Cancer (NSCLC) Patients Harboring EGFR Mutations, Compared With the Use of TKIs Alone

Objective: To explore the efficacy comparison between epidermal growth factor receptor–tyrosine kinase inhibitors (EGFR-TKIs) combined with traditional Chinese medicine (TCM) and single EGFR-TKIs for advanced non-small cell lung cancer (NSCLC). Methods: A total of 91 NSCLC patients with EGFR mutatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yujia, Wu, Guoyu, Li, Ru, Luo, Yingzhe, Huang, Xingmei, He, Lifang, Zhong, Huihui, Xiong, Shaoquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249768/
https://www.ncbi.nlm.nih.gov/pubmed/34222178
http://dx.doi.org/10.3389/fpubh.2021.677862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249768/
https://www.ncbi.nlm.nih.gov/pubmed/34222178
http://dx.doi.org/10.3389/fpubh.2021.677862

Ejemplares similares